Pharma & Healthcare
Global Glucagon Drug Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4294
- Pages: 79
- Figures: 108
- Views: 11
Glucagon is a prescription drug for injection is a gastrointestinal motility inhibitor indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.
The global Glucagon Drug market is projected to grow from US$ 3741 million in 2024 to US$ 5306.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Glucagon Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Glucagon Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Glucagon Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glucagon Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glucagon Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Glucagon Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Fresenius Kabi
Torrent Labs
Segment by Type
Inject Glucagon
Nasal Glucagon
Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Glucagon Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Glucagon Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucagon Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Glucagon Drug market is projected to grow from US$ 3741 million in 2024 to US$ 5306.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Glucagon Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Glucagon Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Glucagon Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glucagon Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glucagon Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Glucagon Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Fresenius Kabi
Torrent Labs
Segment by Type
Inject Glucagon
Nasal Glucagon
Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Glucagon Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Glucagon Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucagon Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Glucagon Drug Product Introduction
1.2 Market by Type
1.2.1 Global Glucagon Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Market by Application
1.3.1 Global Glucagon Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glucagon Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Glucagon Drug Revenue by Region
2.2.1 Global Glucagon Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Glucagon Drug Revenue by Region (2019-2024)
2.2.3 Global Glucagon Drug Revenue by Region (2025-2030)
2.2.4 Global Glucagon Drug Revenue Market Share by Region (2019-2030)
2.3 Global Glucagon Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Glucagon Drug Sales by Region
2.4.1 Global Glucagon Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Glucagon Drug Sales by Region (2019-2024)
2.4.3 Global Glucagon Drug Sales by Region (2025-2030)
2.4.4 Global Glucagon Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Glucagon Drug Sales by Manufacturers
3.1.1 Global Glucagon Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Glucagon Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glucagon Drug in 2023
3.2 Global Glucagon Drug Revenue by Manufacturers
3.2.1 Global Glucagon Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Glucagon Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Glucagon Drug Revenue in 2023
3.3 Global Key Players of Glucagon Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Glucagon Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glucagon Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glucagon Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glucagon Drug, Product Offered and Application
3.8 Global Key Manufacturers of Glucagon Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glucagon Drug Sales by Type
4.1.1 Global Glucagon Drug Historical Sales by Type (2019-2024)
4.1.2 Global Glucagon Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Glucagon Drug Sales Market Share by Type (2019-2030)
4.2 Global Glucagon Drug Revenue by Type
4.2.1 Global Glucagon Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Glucagon Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Glucagon Drug Revenue Market Share by Type (2019-2030)
4.3 Global Glucagon Drug Price by Type
4.3.1 Global Glucagon Drug Price by Type (2019-2024)
4.3.2 Global Glucagon Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Glucagon Drug Sales by Application
5.1.1 Global Glucagon Drug Historical Sales by Application (2019-2024)
5.1.2 Global Glucagon Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Glucagon Drug Sales Market Share by Application (2019-2030)
5.2 Global Glucagon Drug Revenue by Application
5.2.1 Global Glucagon Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Glucagon Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Glucagon Drug Revenue Market Share by Application (2019-2030)
5.3 Global Glucagon Drug Price by Application
5.3.1 Global Glucagon Drug Price by Application (2019-2024)
5.3.2 Global Glucagon Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Glucagon Drug Market Size by Type
6.1.1 US & Canada Glucagon Drug Sales by Type (2019-2030)
6.1.2 US & Canada Glucagon Drug Revenue by Type (2019-2030)
6.2 US & Canada Glucagon Drug Market Size by Application
6.2.1 US & Canada Glucagon Drug Sales by Application (2019-2030)
6.2.2 US & Canada Glucagon Drug Revenue by Application (2019-2030)
6.3 US & Canada Glucagon Drug Market Size by Country
6.3.1 US & Canada Glucagon Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Glucagon Drug Sales by Country (2019-2030)
6.3.3 US & Canada Glucagon Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Glucagon Drug Market Size by Type
7.1.1 Europe Glucagon Drug Sales by Type (2019-2030)
7.1.2 Europe Glucagon Drug Revenue by Type (2019-2030)
7.2 Europe Glucagon Drug Market Size by Application
7.2.1 Europe Glucagon Drug Sales by Application (2019-2030)
7.2.2 Europe Glucagon Drug Revenue by Application (2019-2030)
7.3 Europe Glucagon Drug Market Size by Country
7.3.1 Europe Glucagon Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Glucagon Drug Sales by Country (2019-2030)
7.3.3 Europe Glucagon Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Glucagon Drug Market Size
8.1.1 China Glucagon Drug Sales (2019-2030)
8.1.2 China Glucagon Drug Revenue (2019-2030)
8.2 China Glucagon Drug Market Size by Application
8.2.1 China Glucagon Drug Sales by Application (2019-2030)
8.2.2 China Glucagon Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Glucagon Drug Market Size by Type
9.1.1 Asia Glucagon Drug Sales by Type (2019-2030)
9.1.2 Asia Glucagon Drug Revenue by Type (2019-2030)
9.2 Asia Glucagon Drug Market Size by Application
9.2.1 Asia Glucagon Drug Sales by Application (2019-2030)
9.2.2 Asia Glucagon Drug Revenue by Application (2019-2030)
9.3 Asia Glucagon Drug Sales by Region
9.3.1 Asia Glucagon Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Glucagon Drug Revenue by Region (2019-2030)
9.3.3 Asia Glucagon Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glucagon Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Glucagon Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Glucagon Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Glucagon Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Glucagon Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Glucagon Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Glucagon Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Glucagon Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Glucagon Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Glucagon Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Glucagon Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novo Nordisk Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Overview
11.2.3 Eli Lilly Glucagon Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Eli Lilly Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Glucagon Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Fresenius Kabi Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Torrent Labs
11.4.1 Torrent Labs Company Information
11.4.2 Torrent Labs Overview
11.4.3 Torrent Labs Glucagon Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Torrent Labs Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Torrent Labs Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glucagon Drug Industry Chain Analysis
12.2 Glucagon Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glucagon Drug Production Mode & Process
12.4 Glucagon Drug Sales and Marketing
12.4.1 Glucagon Drug Sales Channels
12.4.2 Glucagon Drug Distributors
12.5 Glucagon Drug Customers
13 Market Dynamics
13.1 Glucagon Drug Industry Trends
13.2 Glucagon Drug Market Drivers
13.3 Glucagon Drug Market Challenges
13.4 Glucagon Drug Market Restraints
14 Key Findings in The Global Glucagon Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Glucagon Drug Product Introduction
1.2 Market by Type
1.2.1 Global Glucagon Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Market by Application
1.3.1 Global Glucagon Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glucagon Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Glucagon Drug Revenue by Region
2.2.1 Global Glucagon Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Glucagon Drug Revenue by Region (2019-2024)
2.2.3 Global Glucagon Drug Revenue by Region (2025-2030)
2.2.4 Global Glucagon Drug Revenue Market Share by Region (2019-2030)
2.3 Global Glucagon Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Glucagon Drug Sales by Region
2.4.1 Global Glucagon Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Glucagon Drug Sales by Region (2019-2024)
2.4.3 Global Glucagon Drug Sales by Region (2025-2030)
2.4.4 Global Glucagon Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Glucagon Drug Sales by Manufacturers
3.1.1 Global Glucagon Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Glucagon Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glucagon Drug in 2023
3.2 Global Glucagon Drug Revenue by Manufacturers
3.2.1 Global Glucagon Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Glucagon Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Glucagon Drug Revenue in 2023
3.3 Global Key Players of Glucagon Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Glucagon Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glucagon Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glucagon Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glucagon Drug, Product Offered and Application
3.8 Global Key Manufacturers of Glucagon Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glucagon Drug Sales by Type
4.1.1 Global Glucagon Drug Historical Sales by Type (2019-2024)
4.1.2 Global Glucagon Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Glucagon Drug Sales Market Share by Type (2019-2030)
4.2 Global Glucagon Drug Revenue by Type
4.2.1 Global Glucagon Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Glucagon Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Glucagon Drug Revenue Market Share by Type (2019-2030)
4.3 Global Glucagon Drug Price by Type
4.3.1 Global Glucagon Drug Price by Type (2019-2024)
4.3.2 Global Glucagon Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Glucagon Drug Sales by Application
5.1.1 Global Glucagon Drug Historical Sales by Application (2019-2024)
5.1.2 Global Glucagon Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Glucagon Drug Sales Market Share by Application (2019-2030)
5.2 Global Glucagon Drug Revenue by Application
5.2.1 Global Glucagon Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Glucagon Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Glucagon Drug Revenue Market Share by Application (2019-2030)
5.3 Global Glucagon Drug Price by Application
5.3.1 Global Glucagon Drug Price by Application (2019-2024)
5.3.2 Global Glucagon Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Glucagon Drug Market Size by Type
6.1.1 US & Canada Glucagon Drug Sales by Type (2019-2030)
6.1.2 US & Canada Glucagon Drug Revenue by Type (2019-2030)
6.2 US & Canada Glucagon Drug Market Size by Application
6.2.1 US & Canada Glucagon Drug Sales by Application (2019-2030)
6.2.2 US & Canada Glucagon Drug Revenue by Application (2019-2030)
6.3 US & Canada Glucagon Drug Market Size by Country
6.3.1 US & Canada Glucagon Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Glucagon Drug Sales by Country (2019-2030)
6.3.3 US & Canada Glucagon Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Glucagon Drug Market Size by Type
7.1.1 Europe Glucagon Drug Sales by Type (2019-2030)
7.1.2 Europe Glucagon Drug Revenue by Type (2019-2030)
7.2 Europe Glucagon Drug Market Size by Application
7.2.1 Europe Glucagon Drug Sales by Application (2019-2030)
7.2.2 Europe Glucagon Drug Revenue by Application (2019-2030)
7.3 Europe Glucagon Drug Market Size by Country
7.3.1 Europe Glucagon Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Glucagon Drug Sales by Country (2019-2030)
7.3.3 Europe Glucagon Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Glucagon Drug Market Size
8.1.1 China Glucagon Drug Sales (2019-2030)
8.1.2 China Glucagon Drug Revenue (2019-2030)
8.2 China Glucagon Drug Market Size by Application
8.2.1 China Glucagon Drug Sales by Application (2019-2030)
8.2.2 China Glucagon Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Glucagon Drug Market Size by Type
9.1.1 Asia Glucagon Drug Sales by Type (2019-2030)
9.1.2 Asia Glucagon Drug Revenue by Type (2019-2030)
9.2 Asia Glucagon Drug Market Size by Application
9.2.1 Asia Glucagon Drug Sales by Application (2019-2030)
9.2.2 Asia Glucagon Drug Revenue by Application (2019-2030)
9.3 Asia Glucagon Drug Sales by Region
9.3.1 Asia Glucagon Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Glucagon Drug Revenue by Region (2019-2030)
9.3.3 Asia Glucagon Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glucagon Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Glucagon Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Glucagon Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Glucagon Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Glucagon Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Glucagon Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Glucagon Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Glucagon Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Glucagon Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Glucagon Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Glucagon Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novo Nordisk Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Overview
11.2.3 Eli Lilly Glucagon Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Eli Lilly Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Glucagon Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Fresenius Kabi Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Torrent Labs
11.4.1 Torrent Labs Company Information
11.4.2 Torrent Labs Overview
11.4.3 Torrent Labs Glucagon Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Torrent Labs Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Torrent Labs Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glucagon Drug Industry Chain Analysis
12.2 Glucagon Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glucagon Drug Production Mode & Process
12.4 Glucagon Drug Sales and Marketing
12.4.1 Glucagon Drug Sales Channels
12.4.2 Glucagon Drug Distributors
12.5 Glucagon Drug Customers
13 Market Dynamics
13.1 Glucagon Drug Industry Trends
13.2 Glucagon Drug Market Drivers
13.3 Glucagon Drug Market Challenges
13.4 Glucagon Drug Market Restraints
14 Key Findings in The Global Glucagon Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Glucagon Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Inject Glucagon
Table 3. Major Manufacturers of Nasal Glucagon
Table 4. Global Glucagon Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Glucagon Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Glucagon Drug Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Glucagon Drug Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Glucagon Drug Revenue Market Share by Region (2019-2024)
Table 9. Global Glucagon Drug Revenue Market Share by Region (2025-2030)
Table 10. Global Glucagon Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Glucagon Drug Sales by Region (2019-2024) & (K Units)
Table 12. Global Glucagon Drug Sales by Region (2025-2030) & (K Units)
Table 13. Global Glucagon Drug Sales Market Share by Region (2019-2024)
Table 14. Global Glucagon Drug Sales Market Share by Region (2025-2030)
Table 15. Global Glucagon Drug Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Glucagon Drug Sales Share by Manufacturers (2019-2024)
Table 17. Global Glucagon Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Glucagon Drug Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Glucagon Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Glucagon Drug Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Glucagon Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Glucagon Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Drug as of 2023)
Table 23. Global Key Manufacturers of Glucagon Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Glucagon Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Glucagon Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 28. Global Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 29. Global Glucagon Drug Sales Share by Type (2019-2024)
Table 30. Global Glucagon Drug Sales Share by Type (2025-2030)
Table 31. Global Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Glucagon Drug Revenue Share by Type (2019-2024)
Table 34. Global Glucagon Drug Revenue Share by Type (2025-2030)
Table 35. Glucagon Drug Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Glucagon Drug Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 38. Global Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 39. Global Glucagon Drug Sales Share by Application (2019-2024)
Table 40. Global Glucagon Drug Sales Share by Application (2025-2030)
Table 41. Global Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Glucagon Drug Revenue Share by Application (2019-2024)
Table 44. Global Glucagon Drug Revenue Share by Application (2025-2030)
Table 45. Glucagon Drug Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Glucagon Drug Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Glucagon Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Glucagon Drug Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Glucagon Drug Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Glucagon Drug Sales by Country (2025-2030) & (K Units)
Table 60. Europe Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 61. Europe Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 62. Europe Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 65. Europe Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 66. Europe Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Glucagon Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Glucagon Drug Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Glucagon Drug Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 72. Europe Glucagon Drug Sales by Country (2025-2030) & (K Units)
Table 73. China Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 74. China Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 75. China Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 78. China Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 79. China Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 82. Asia Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 83. Asia Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 86. Asia Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 87. Asia Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Glucagon Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Glucagon Drug Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Glucagon Drug Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Glucagon Drug Sales by Region (2019-2024) & (K Units)
Table 93. Asia Glucagon Drug Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Glucagon Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Glucagon Drug Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Glucagon Drug Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Glucagon Drug Sales by Country (2025-2030) & (K Units)
Table 107. Novo Nordisk Company Information
Table 108. Novo Nordisk Description and Major Businesses
Table 109. Novo Nordisk Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Novo Nordisk Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novo Nordisk Recent Developments
Table 112. Eli Lilly Company Information
Table 113. Eli Lilly Description and Major Businesses
Table 114. Eli Lilly Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Eli Lilly Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Eli Lilly Recent Developments
Table 117. Fresenius Kabi Company Information
Table 118. Fresenius Kabi Description and Major Businesses
Table 119. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Fresenius Kabi Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Fresenius Kabi Recent Developments
Table 122. Torrent Labs Company Information
Table 123. Torrent Labs Description and Major Businesses
Table 124. Torrent Labs Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Torrent Labs Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Torrent Labs Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Glucagon Drug Distributors List
Table 130. Glucagon Drug Customers List
Table 131. Glucagon Drug Market Trends
Table 132. Glucagon Drug Market Drivers
Table 133. Glucagon Drug Market Challenges
Table 134. Glucagon Drug Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Drug Product Picture
Figure 2. Global Glucagon Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Glucagon Drug Market Share by Type in 2023 & 2030
Figure 4. Inject Glucagon Product Picture
Figure 5. Nasal Glucagon Product Picture
Figure 6. Global Glucagon Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Glucagon Drug Market Share by Application in 2023 & 2030
Figure 8. Emergency Kits
Figure 9. General Use
Figure 10. Diagnostic & Motility
Figure 11. Cardiogenic Shock
Figure 12. Others
Figure 13. Glucagon Drug Report Years Considered
Figure 14. Global Glucagon Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Glucagon Drug Revenue 2019-2030 (US$ Million)
Figure 16. Global Glucagon Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Glucagon Drug Revenue Market Share by Region (2019-2030)
Figure 18. Global Glucagon Drug Sales 2019-2030 ((K Units)
Figure 19. Global Glucagon Drug Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 21. US & Canada Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 23. Europe Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 25. China Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 27. Asia (excluding China) Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 29. Middle East, Africa and Latin America Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Glucagon Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. The Top 5 and 10 Largest Manufacturers of Glucagon Drug in the World: Market Share by Glucagon Drug Revenue in 2023
Figure 32. Global Glucagon Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 34. Global Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 35. Global Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 36. Global Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 37. US & Canada Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 38. US & Canada Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 39. US & Canada Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 40. US & Canada Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 41. US & Canada Glucagon Drug Revenue Share by Country (2019-2030)
Figure 42. US & Canada Glucagon Drug Sales Share by Country (2019-2030)
Figure 43. U.S. Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 46. Europe Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 47. Europe Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 48. Europe Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 49. Europe Glucagon Drug Revenue Share by Country (2019-2030)
Figure 50. Europe Glucagon Drug Sales Share by Country (2019-2030)
Figure 51. Germany Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 52. France Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 53. U.K. Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 54. Italy Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 55. Russia Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 56. China Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 57. China Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 58. China Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 59. China Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 60. Asia Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 61. Asia Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 62. Asia Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 63. Asia Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 64. Asia Glucagon Drug Revenue Share by Region (2019-2030)
Figure 65. Asia Glucagon Drug Sales Share by Region (2019-2030)
Figure 66. Japan Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 67. South Korea Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 68. China Taiwan Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 69. Southeast Asia Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 70. India Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Glucagon Drug Revenue Share by Country (2019-2030)
Figure 76. Middle East, Africa and Latin America Glucagon Drug Sales Share by Country (2019-2030)
Figure 77. Brazil Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 78. Mexico Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 79. Turkey Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 80. Israel Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 81. GCC Countries Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 82. Glucagon Drug Value Chain
Figure 83. Glucagon Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Table 1. Global Glucagon Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Inject Glucagon
Table 3. Major Manufacturers of Nasal Glucagon
Table 4. Global Glucagon Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Glucagon Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Glucagon Drug Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Glucagon Drug Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Glucagon Drug Revenue Market Share by Region (2019-2024)
Table 9. Global Glucagon Drug Revenue Market Share by Region (2025-2030)
Table 10. Global Glucagon Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Glucagon Drug Sales by Region (2019-2024) & (K Units)
Table 12. Global Glucagon Drug Sales by Region (2025-2030) & (K Units)
Table 13. Global Glucagon Drug Sales Market Share by Region (2019-2024)
Table 14. Global Glucagon Drug Sales Market Share by Region (2025-2030)
Table 15. Global Glucagon Drug Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Glucagon Drug Sales Share by Manufacturers (2019-2024)
Table 17. Global Glucagon Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Glucagon Drug Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Glucagon Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Glucagon Drug Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Glucagon Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Glucagon Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Drug as of 2023)
Table 23. Global Key Manufacturers of Glucagon Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Glucagon Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Glucagon Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 28. Global Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 29. Global Glucagon Drug Sales Share by Type (2019-2024)
Table 30. Global Glucagon Drug Sales Share by Type (2025-2030)
Table 31. Global Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Glucagon Drug Revenue Share by Type (2019-2024)
Table 34. Global Glucagon Drug Revenue Share by Type (2025-2030)
Table 35. Glucagon Drug Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Glucagon Drug Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 38. Global Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 39. Global Glucagon Drug Sales Share by Application (2019-2024)
Table 40. Global Glucagon Drug Sales Share by Application (2025-2030)
Table 41. Global Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Glucagon Drug Revenue Share by Application (2019-2024)
Table 44. Global Glucagon Drug Revenue Share by Application (2025-2030)
Table 45. Glucagon Drug Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Glucagon Drug Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Glucagon Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Glucagon Drug Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Glucagon Drug Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Glucagon Drug Sales by Country (2025-2030) & (K Units)
Table 60. Europe Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 61. Europe Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 62. Europe Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 65. Europe Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 66. Europe Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Glucagon Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Glucagon Drug Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Glucagon Drug Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 72. Europe Glucagon Drug Sales by Country (2025-2030) & (K Units)
Table 73. China Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 74. China Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 75. China Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 78. China Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 79. China Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 82. Asia Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 83. Asia Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 86. Asia Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 87. Asia Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Glucagon Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Glucagon Drug Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Glucagon Drug Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Glucagon Drug Sales by Region (2019-2024) & (K Units)
Table 93. Asia Glucagon Drug Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Glucagon Drug Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Glucagon Drug Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Glucagon Drug Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Glucagon Drug Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Glucagon Drug Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Glucagon Drug Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Glucagon Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Glucagon Drug Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Glucagon Drug Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Glucagon Drug Sales by Country (2025-2030) & (K Units)
Table 107. Novo Nordisk Company Information
Table 108. Novo Nordisk Description and Major Businesses
Table 109. Novo Nordisk Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Novo Nordisk Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novo Nordisk Recent Developments
Table 112. Eli Lilly Company Information
Table 113. Eli Lilly Description and Major Businesses
Table 114. Eli Lilly Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Eli Lilly Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Eli Lilly Recent Developments
Table 117. Fresenius Kabi Company Information
Table 118. Fresenius Kabi Description and Major Businesses
Table 119. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Fresenius Kabi Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Fresenius Kabi Recent Developments
Table 122. Torrent Labs Company Information
Table 123. Torrent Labs Description and Major Businesses
Table 124. Torrent Labs Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Torrent Labs Glucagon Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Torrent Labs Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Glucagon Drug Distributors List
Table 130. Glucagon Drug Customers List
Table 131. Glucagon Drug Market Trends
Table 132. Glucagon Drug Market Drivers
Table 133. Glucagon Drug Market Challenges
Table 134. Glucagon Drug Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Drug Product Picture
Figure 2. Global Glucagon Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Glucagon Drug Market Share by Type in 2023 & 2030
Figure 4. Inject Glucagon Product Picture
Figure 5. Nasal Glucagon Product Picture
Figure 6. Global Glucagon Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Glucagon Drug Market Share by Application in 2023 & 2030
Figure 8. Emergency Kits
Figure 9. General Use
Figure 10. Diagnostic & Motility
Figure 11. Cardiogenic Shock
Figure 12. Others
Figure 13. Glucagon Drug Report Years Considered
Figure 14. Global Glucagon Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Glucagon Drug Revenue 2019-2030 (US$ Million)
Figure 16. Global Glucagon Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Glucagon Drug Revenue Market Share by Region (2019-2030)
Figure 18. Global Glucagon Drug Sales 2019-2030 ((K Units)
Figure 19. Global Glucagon Drug Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 21. US & Canada Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 23. Europe Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 25. China Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 27. Asia (excluding China) Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Glucagon Drug Sales YoY (2019-2030) & (K Units)
Figure 29. Middle East, Africa and Latin America Glucagon Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Glucagon Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. The Top 5 and 10 Largest Manufacturers of Glucagon Drug in the World: Market Share by Glucagon Drug Revenue in 2023
Figure 32. Global Glucagon Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 34. Global Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 35. Global Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 36. Global Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 37. US & Canada Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 38. US & Canada Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 39. US & Canada Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 40. US & Canada Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 41. US & Canada Glucagon Drug Revenue Share by Country (2019-2030)
Figure 42. US & Canada Glucagon Drug Sales Share by Country (2019-2030)
Figure 43. U.S. Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 46. Europe Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 47. Europe Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 48. Europe Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 49. Europe Glucagon Drug Revenue Share by Country (2019-2030)
Figure 50. Europe Glucagon Drug Sales Share by Country (2019-2030)
Figure 51. Germany Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 52. France Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 53. U.K. Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 54. Italy Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 55. Russia Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 56. China Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 57. China Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 58. China Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 59. China Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 60. Asia Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 61. Asia Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 62. Asia Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 63. Asia Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 64. Asia Glucagon Drug Revenue Share by Region (2019-2030)
Figure 65. Asia Glucagon Drug Sales Share by Region (2019-2030)
Figure 66. Japan Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 67. South Korea Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 68. China Taiwan Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 69. Southeast Asia Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 70. India Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Glucagon Drug Sales Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Glucagon Drug Revenue Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Glucagon Drug Sales Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Glucagon Drug Revenue Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Glucagon Drug Revenue Share by Country (2019-2030)
Figure 76. Middle East, Africa and Latin America Glucagon Drug Sales Share by Country (2019-2030)
Figure 77. Brazil Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 78. Mexico Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 79. Turkey Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 80. Israel Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 81. GCC Countries Glucagon Drug Revenue (2019-2030) & (US$ Million)
Figure 82. Glucagon Drug Value Chain
Figure 83. Glucagon Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Mining Truck Mounted Drill Rigs Market Research Report 2025
Apr 07, 25
Global Bulk Material Drag Chain Conveyor Market Research Report 2025
Apr 07, 25
Global Boom-type Mining Roadheader Market Research Report 2025
Apr 07, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232